Laurie J Zandberg1, David Rosenfield2, Elizabeth Alpert3, Carmen P McLean3, Edna B Foa3. 1. Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: zandberg@mail.med.upenn.edu. 2. Department of Psychology, Southern Methodist University, Dallas, TX, USA. 3. Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
OBJECTIVE: The present study examined predictors and moderators of dropout among 165 adults meeting DSM-IV criteria for posttraumatic stress disorder (PTSD) andalcohol dependence (AD). Participants were randomized to 24 weeks of naltrexone (NAL), NAL and prolonged exposure (PE), pill placebo, or pill placebo and PE. All participants received supportive AD counseling (the BRENDA manualized model). METHOD: Logistic regression using the Fournier approach was conducted to investigate baseline predictors of dropout across the entire study sample. Rates of PTSD and AD symptom improvement were included to evaluate the impact of symptom change on dropout. RESULTS:Trauma type and rates of PTSD and AD improvement significantly predicted dropout, accounting for 76% of the variance in dropout. Accidents and "other" trauma were associated with the highest dropout, and physical assault was associated with the lowest dropout. For participants with low baseline PTSD severity, faster PTSD improvement predicted higher dropout. For those with high baseline severity, both very fast and very slow rates of PTSD improvement were associated with higher dropout. Faster rates of drinking improvement predicted higher dropout among participants who received PE. CONCLUSIONS: The current study highlights the influence of symptom trajectory on dropout risk. Clinicians may improve retention in PTSD-AD treatments by monitoring symptom change at regular intervals, and eliciting patient feedback on these changes.
RCT Entities:
OBJECTIVE: The present study examined predictors and moderators of dropout among 165 adults meeting DSM-IV criteria for posttraumatic stress disorder (PTSD) and alcohol dependence (AD). Participants were randomized to 24 weeks of naltrexone (NAL), NAL and prolonged exposure (PE), pill placebo, or pill placebo and PE. All participants received supportive AD counseling (the BRENDA manualized model). METHOD: Logistic regression using the Fournier approach was conducted to investigate baseline predictors of dropout across the entire study sample. Rates of PTSD and AD symptom improvement were included to evaluate the impact of symptom change on dropout. RESULTS:Trauma type and rates of PTSD and AD improvement significantly predicted dropout, accounting for 76% of the variance in dropout. Accidents and "other" trauma were associated with the highest dropout, and physical assault was associated with the lowest dropout. For participants with low baseline PTSD severity, faster PTSD improvement predicted higher dropout. For those with high baseline severity, both very fast and very slow rates of PTSD improvement were associated with higher dropout. Faster rates of drinking improvement predicted higher dropout among participants who received PE. CONCLUSIONS: The current study highlights the influence of symptom trajectory on dropout risk. Clinicians may improve retention in PTSD-AD treatments by monitoring symptom change at regular intervals, and eliciting patient feedback on these changes.
Authors: Jay C Fournier; Robert J DeRubeis; Richard C Shelton; Steven D Hollon; Jay D Amsterdam; Robert Gallop Journal: J Consult Clin Psychol Date: 2009-08
Authors: Emily L Belleau; Eu Gene Chin; Sonya G Wanklyn; Laura Zambrano-Vazquez; Julie A Schumacher; Scott F Coffey Journal: Behav Res Ther Date: 2017-01-25
Authors: Jolene Jacquart; Santiago Papini; Michelle L Davis; David Rosenfield; Mark B Powers; Georita M Frierson; Lindsey B Hopkins; Scarlett O Baird; Bess H Marcus; Timothy S Church; Michael W Otto; Michael J Zvolensky; Jasper A J Smits Journal: Drug Alcohol Depend Date: 2017-03-06 Impact factor: 4.492
Authors: Sudie E Back; Therese Killeen; Christal L Badour; Julianne C Flanagan; Nicholas P Allan; Elizabeth Santa Ana; Brian Lozano; Kristina J Korte; Edna B Foa; Kathleen T Brady Journal: Addict Behav Date: 2018-11-27 Impact factor: 3.913
Authors: Derek D Szafranski; Alexandra Snead; Nicholas P Allan; Daniel F Gros; Therese Killeen; Julianne Flanagan; Irene Pericot-Valverde; Sudie E Back Journal: Addict Behav Date: 2017-04-04 Impact factor: 3.913
Authors: Amber M Jarnecke; Nicholas P Allan; Christal L Badour; Julianne C Flanagan; Therese K Killeen; Sudie E Back Journal: Addict Behav Date: 2018-10-16 Impact factor: 3.913
Authors: Carly Yasinski; Adele M Hayes; Elizabeth Alpert; Thomas McCauley; C Beth Ready; Charles Webb; Esther Deblinger Journal: Behav Res Ther Date: 2018-05-23
Authors: Delisa G Brown; Julianne C Flanagan; Amber Jarnecke; Therese K Killeen; Sudie E Back Journal: J Ethn Subst Abuse Date: 2020-10-28 Impact factor: 1.331